Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
BackgroundObesity is a multifactorial disease, which is strongly associated to other metabolic disorders. Bariatric surgery is the most effective treatment of morbid obesity. The role of beta cell function in weight loss after bariatric surgery is uncertain.AimTo evaluate the association between bet...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.714173/full |
id |
doaj-e989f6eb6870429f9ae388d2b3fa4e17 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marta Borges-Canha Marta Borges-Canha João Sérgio Neves João Sérgio Neves Fernando Mendonça Maria Manuel Silva Cláudia Costa Pedro M. Cabral Vanessa Guerreiro Rita Lourenço Patrícia Meira Daniela Salazar Maria João Ferreira Jorge Pedro Ebrahim Barkoudah Ana Sande Eva Lau Selma B. Souto John Preto Paula Freitas Paula Freitas Davide Carvalho Davide Carvalho |
spellingShingle |
Marta Borges-Canha Marta Borges-Canha João Sérgio Neves João Sérgio Neves Fernando Mendonça Maria Manuel Silva Cláudia Costa Pedro M. Cabral Vanessa Guerreiro Rita Lourenço Patrícia Meira Daniela Salazar Maria João Ferreira Jorge Pedro Ebrahim Barkoudah Ana Sande Eva Lau Selma B. Souto John Preto Paula Freitas Paula Freitas Davide Carvalho Davide Carvalho Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery Frontiers in Endocrinology beta cell function insulin resistance bariatric surgery morbid obesity weight loss |
author_facet |
Marta Borges-Canha Marta Borges-Canha João Sérgio Neves João Sérgio Neves Fernando Mendonça Maria Manuel Silva Cláudia Costa Pedro M. Cabral Vanessa Guerreiro Rita Lourenço Patrícia Meira Daniela Salazar Maria João Ferreira Jorge Pedro Ebrahim Barkoudah Ana Sande Eva Lau Selma B. Souto John Preto Paula Freitas Paula Freitas Davide Carvalho Davide Carvalho |
author_sort |
Marta Borges-Canha |
title |
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery |
title_short |
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery |
title_full |
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery |
title_fullStr |
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery |
title_full_unstemmed |
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery |
title_sort |
beta cell function as a baseline predictor of weight loss after bariatric surgery |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2021-08-01 |
description |
BackgroundObesity is a multifactorial disease, which is strongly associated to other metabolic disorders. Bariatric surgery is the most effective treatment of morbid obesity. The role of beta cell function in weight loss after bariatric surgery is uncertain.AimTo evaluate the association between beta cell function and percentage of total body weight loss (TBWL%) 1, 2, 3, and 4 years after bariatric surgery in patients with morbid obesity.MethodsRetrospective longitudinal study in patients with morbid obesity followed in our center between January 2010 and July 2018. Patients were excluded if they had diabetes at baseline or missing data on the needed parameters. We evaluated baseline Homeostatic Model Assessment of IR, Homeostatic Model Assessment of β-cell function (HOMA-beta), Quantitative Insulin Sensitivity Check Index, and Matsuda and DeFronzo index, and TBWL% at years 1 to 4. Linear regression models were used to evaluate the association of indexes of insulin resistance with TBWL% (unadjusted and adjusted for age, sex, BMI, and type of surgery).ResultsThere were 1,561 patients included in this analysis. HOMA-beta was negatively associated with TBWL% at second, third, and fourth years post-surgery (β = −1.04 [−1.82 to −0.26], p<0.01; β = −1.16 [−2.13 to −0.19], p=0.02; β = −1.29 [−2.64 to 0.06], p=0.061, respectively). This was not observed in the first year post-surgery nor for the other indexes. Glycemia at baseline was positively associated to EWL% at second and third years post-surgery.Conclusionβ-cell function at baseline seems to be associated to long-term weight loss, explicitly after the first year post bariatric surgery. This might be a helpful predictor of weight loss in clinical practice. |
topic |
beta cell function insulin resistance bariatric surgery morbid obesity weight loss |
url |
https://www.frontiersin.org/articles/10.3389/fendo.2021.714173/full |
work_keys_str_mv |
AT martaborgescanha betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT martaborgescanha betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT joaosergioneves betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT joaosergioneves betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT fernandomendonca betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT mariamanuelsilva betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT claudiacosta betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT pedromcabral betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT vanessaguerreiro betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT ritalourenco betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT patriciameira betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT danielasalazar betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT mariajoaoferreira betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT jorgepedro betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT ebrahimbarkoudah betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT anasande betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT evalau betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT selmabsouto betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT johnpreto betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT paulafreitas betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT paulafreitas betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT davidecarvalho betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery AT davidecarvalho betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery |
_version_ |
1721209820149710848 |
spelling |
doaj-e989f6eb6870429f9ae388d2b3fa4e172021-08-12T04:48:12ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-08-011210.3389/fendo.2021.714173714173Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric SurgeryMarta Borges-Canha0Marta Borges-Canha1João Sérgio Neves2João Sérgio Neves3Fernando Mendonça4Maria Manuel Silva5Cláudia Costa6Pedro M. Cabral7Vanessa Guerreiro8Rita Lourenço9Patrícia Meira10Daniela Salazar11Maria João Ferreira12Jorge Pedro13Ebrahim Barkoudah14Ana Sande15Eva Lau16Selma B. Souto17John Preto18Paula Freitas19Paula Freitas20Davide Carvalho21Davide Carvalho22Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalDepartamento de Cirurgia e Fisiologia, Faculdade de Medicina da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalDepartamento de Cirurgia e Fisiologia, Faculdade de Medicina da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia do Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Porto, PortugalServiço de Patologia Clínica do Centro Hospitalar Universitário Cova da Beira, EPE, Covilhã, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalFaculdade de Ciências da Nutrição e Alimentação da Universidade do Porto, Porto, PortugalFaculdade de Ciências da Nutrição e Alimentação da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalDepartment of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United StatesServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Cirurgia Geral do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalInvestigação e Inovação em Saúde (i3s), Faculdade de Medicina da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalInvestigação e Inovação em Saúde (i3s), Faculdade de Medicina da Universidade do Porto, Porto, PortugalBackgroundObesity is a multifactorial disease, which is strongly associated to other metabolic disorders. Bariatric surgery is the most effective treatment of morbid obesity. The role of beta cell function in weight loss after bariatric surgery is uncertain.AimTo evaluate the association between beta cell function and percentage of total body weight loss (TBWL%) 1, 2, 3, and 4 years after bariatric surgery in patients with morbid obesity.MethodsRetrospective longitudinal study in patients with morbid obesity followed in our center between January 2010 and July 2018. Patients were excluded if they had diabetes at baseline or missing data on the needed parameters. We evaluated baseline Homeostatic Model Assessment of IR, Homeostatic Model Assessment of β-cell function (HOMA-beta), Quantitative Insulin Sensitivity Check Index, and Matsuda and DeFronzo index, and TBWL% at years 1 to 4. Linear regression models were used to evaluate the association of indexes of insulin resistance with TBWL% (unadjusted and adjusted for age, sex, BMI, and type of surgery).ResultsThere were 1,561 patients included in this analysis. HOMA-beta was negatively associated with TBWL% at second, third, and fourth years post-surgery (β = −1.04 [−1.82 to −0.26], p<0.01; β = −1.16 [−2.13 to −0.19], p=0.02; β = −1.29 [−2.64 to 0.06], p=0.061, respectively). This was not observed in the first year post-surgery nor for the other indexes. Glycemia at baseline was positively associated to EWL% at second and third years post-surgery.Conclusionβ-cell function at baseline seems to be associated to long-term weight loss, explicitly after the first year post bariatric surgery. This might be a helpful predictor of weight loss in clinical practice.https://www.frontiersin.org/articles/10.3389/fendo.2021.714173/fullbeta cell functioninsulin resistancebariatric surgerymorbid obesityweight loss |